UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 243.

A

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; T Ye, H; Fahey, A; ... Yong, KL; + view all (2004) Impaired bone marrow homing of cytokine-activated CD34(+) cells in the NOD/SCID model. BLOOD , 103 (6) 2079 - 2087. 10.1182/blood-2003-06-1770.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; Ye, HT; Fahey, A; ... Yong, KL; + view all (2004) Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood , 103 (6) pp. 2079-2087. 10.1182/blood-2003-06-1770. Green open access
file

Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) Increased expression of the low affinity IgG receptor FcR gamma IIA (CD32) in platelet RNA from patients with chronic myeloproliferative disorders demonstrated by representational difference analysis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 39 - 39). BLACKWELL PUBLISHING LTD

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; Porter, JB; ... Pennell, DJ; + view all (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. British Journal of Haematology , 127 (3) pp. 348-355. 10.1111/j.1365-2141.2004.05202.x.

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; Porter, JB; ... Pennell, DJ; + view all (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance. BRIT J HAEMATOL , 127 (3) 348 - 355. 10.1111/j.1365-2141.2004.05202.x.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; ... Fielding, A; + view all (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. LEUKEMIA , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; ... Fielding, A; + view all (2004) Inihibitor of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Aubert, G.; (2004) Molecular detection, monitoring and modulation of antigen specific immune responses. Doctoral thesis , University of London. Green open access
file

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, DW; Linch, D; ... Mackinnon, S; + view all (2004) Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant , 34 (2) pp. 137-142. 10.1038/sj.bmt.1704538.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; ... MacKinnon, S; + view all (2004) Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. BIOL BLOOD MARROW TR , 10 (3) 186 - 194. 10.1016/j.bbmt.2003.11.001.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; ... Mackinnon, S; + view all (2004) Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant , 10 (3) pp. 186-194. 10.1016/j.bbmt.2003.11.001.

B

Balsa, C; Watts, MJ; Ings, SJ; Linch, DC; (2004) Unexpected differences in the thaw clonogenic recovery of pre-stressed peripheral blood stem cells according to the cryoprotectant used. In: BONE MARROW TRANSPLANTATION. (pp. S93 - S93). NATURE PUBLISHING GROUP

Barber, L; Whitelegg, A; Madrigal, J; Banner, N; Rose, M; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2004) Lysosomal diseases: natural course, pathology and therapy. [Book]. (Vol.94, Su). Taylor & Francis

Beck, M; Ricci, R; Widmer, U; Dehout, F; Garciade, L; Kampmann, C; Linhart, A; ... Mehta, A; + view all (2004) Fabry disease: overall effects of agalsidase alfa treatment. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 Dec (12) pp. 838-44.

Benchaouir, R; Rameau, P; Decraene, C; Dreyfus, P; Israeli, D; Piétu, G; Danos, O; (2004) Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res , 294 (1) pp. 254-268. 10.1016/j.yexcr.2003.11.005.

Boven, L; van, M; Boot, R; Mehta, A; Boon, L; Aerts, J; Laman, J; (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. AMERICAN JOURNAL OF CLINICAL PATHOLOGY , 122 (3) pp. 359-369.

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; Shaw, A; ... Cavill, I; + view all (2004) Prediction of response to recombinant erythropoietin plus granulocyte-colony stimulating factor following a single subcutaneous bolus in patients with myelodysplastic syndromes; a randomised placebo controlled study. In: BLOOD. (pp. 402A - 402A). AMER SOC HEMATOLOGY

Brooks, SP; Ebenezer, N; Poopalasundaram, S; Maher, E; Francis, P; Moore, A; Hardcastle, A; (2004) Refinement of the X-linked cataract locus (CXN) and gene analysis for CXN and Nance-Horan syndrome (NHS). Ophthalmic Genet , 25 (2) pp. 121-131.

Brooks, SP; Ebenezer, ND; Poopalasundaram, S; Lehmann, OJ; Moore, AT; Hardcastle, AJ; (2004) Identification of the gene for Nance-Horan syndrome (NHS). J MED GENET , 41 (10) 768 - 771. 10.1136/jmg.2004.022517.

Bruno, L; Hoffman, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; ... Enver, T; + view all (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Molecular and Cellular Biology , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Bruno, L; Hoffmann, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; ... Enver, T; + view all (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. MOLECULAR AND CELLULAR BIOLOGY , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Burns, S; Hardy, SJ; Buddle, J; Yong, KL; Jones, GE; Thrasher, AJ; (2004) Maturation of DC is associated with changes in motile characteristics and adherence. CELL MOTIL CYTOSKEL , 57 (2) 118 - 132. 10.1002/cm.10163.

Burton, C; Ell, P; Linch, D; (2004) The role of PET imaging in lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 126 (6) pp. 772-784. 10.1111/j.1365-2141.2004.05069.x.

Buyck, HC; Paston, SJ; Lowdell, MW; MacKinnon, S; Emery, VC; (2004) Functional helper T cell response to CMV predicts probability of CMV vireamia following allogeneic stem cell transplantation. In: BLOOD. (pp. 611A - 611A). AMER SOC HEMATOLOGY

C

Callies, S; de Alwis, DP; Mehta, A; Burgess, M; Aarons, L; (2004) Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979). Cancer Chemotherapy and Pharmacology , 54 (1) pp. 39-48.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. BLOOD COAGUL FIBRIN , 15 (2) 139 - 147. 10.1097/01.mbc.0000114378.15192.1a.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A β-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagulation and Fibrinolysis , 15 (2) pp. 139-147. 10.1097/00001721-200403000-00005.

Castillon, N; Avril-Delplanque, A; Coraux, C; Delenda, C; Péault, B; Danos, O; Puchelle, E; (2004) Regeneration of a well-differentiated human airway surface epithelium by spheroid and lentivirus vector-transduced airway cells. J Gene Med , 6 (8) pp. 846-856. 10.1002/jgm.570.

Cavenagh, JD; Popat, R; Curry, N; Stec, J; Morris, TC; Drake, M; Agrawal, S; ... Oakervee, H; + view all (2004) PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 413A-413A). AMER SOC HEMATOLOGY

Chatterjee, R.; Palla, K.; Kottaridis, P.D.; (2004) Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantation. Journal of Clinical Oncology , 22 (11) pp. 2253-2254. 10.1200/JCO.2004.99.556.

Clark, FJ; Gregg, R; Piper, K; Dunnion, D; Freeman, L; Griffiths, M; Begum, G; ... Chakraverty, R; + view all (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4(+)CD25(high) regulatory T cells. BLOOD , 103 (6) 2410 - 2416. 10.1182/blood-2003-06-2073.

Coakley, M; Mallet, S; Purdy, G; Self, R; Machin, SJ; Mackie, IJ; (2004) A second cohort of patients with coronary heart disease and reduced VWF cleaving protease activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Cohen, H; (2004) Highlights from the 7th annual report: taking SHOT recommendations forward. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Jones, H; Stainsby, D; (2004) SHOT 6th annual report - errors remain the predominant finding. In: (Proceedings) British society for haematology annual scientific meeting.

Cohen, H; Nash, M; Cohen, H; Liesner, R; Machin, SJ; (2004) Acquired coagulation disorders. In: Hoffbrand, V and Lewis, M and Tuddenham, E, (eds.) Postgraduate haematology.

Cooper, N; Avivi, I; Peggs, K; Hart, D; Thomson, K; Goldstone, A; Linch, D; ... Mackinnon, S; + view all (2004) The role of PET scanning in directing immune manipulations following reduced intensity transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 622A - 623A). AMER SOC HEMATOLOGY

Craig, CEH; Quaglia, A; Selden, C; Lowdell, M; Hodgson, H; Dhillon, AP; (2004) The histopathology of regeneration in massive hepatic necrosis. SEMIN LIVER DIS , 24 (1) 49 - 64.

D

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; ... Williams, CD; + view all (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British Journal of Haematology , 125 (6) pp. 756-765. 10.1111/j.1365-2141.2004.04981.x.

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; ... Williams, CD; + view all (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. BRIT J HAEMATOL , 125 (6) 756 - 765. 10.1111/j.1365-2141.2004.04981.x.

Davidoff, AM; Nathwani, AC; (2004) Antiangiogenic gene therapy for cancer treatment. Curr Hematol Rep , 3 (4) pp. 267-273.

Davidoff, AM; Ng, CYC; Sleep, S; Gray, J; Azam, S; Zhao, Y; McIntosh, JH; ... Nathwani, AC; + view all (2004) Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J VIROL METHODS , 121 (2) 209 - 215. 10.1016/j.jviromet.2004.07.001.

Davies, J; Marden, C; Sviland, L; North, J; Lowdell, MW; (2004) Ex-vivo alloreactive T cell depletion with anti-CD69 - Effects on anti-viral immune-reactivity and donor NK cell function. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 198.

Davies, JK; Koh, MBC; Lowdell, MW; (2004) Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. BIOL BLOOD MARROW TR , 10 (4) 259 - 268. 10.1016/j.bbmt.2003.12.001.

Davis, BA; O'Sullivan, C; Jarritt, PH; Porter, JB; (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. BLOOD , 104 (1) 263 - 269. 10.1182/blood-2003-08-2841.

Delaunay, J; Nouyrigat, V; Proust, A; Schischmanoff, P-O; Cynober, T; Yvart, J; Gaillard, C; ... Tchernia, G; + view all (2004) Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans. Br J Haematol , 127 (1) pp. 118-122. 10.1111/j.1365-2141.2004.05160.x.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Kottaridis, P; Peggs, K; Mackinnon, S; (2004) The importance of age, fludarabine and total body irradiation in the incidence and severity of chronic renal failure following allogeneic hematopoietic stem cell transplantation. In: BLOOD. (pp. 621A - 621A). AMER SOC HEMATOLOGY

Dolan, A; Cunningham, C; Hector, RD; Hassan-Walker, AF; Lee, L; Addison, C; Dargan, DJ; ... Davison, AJ; + view all (2004) Genetic content of wild-type human cytomegalovirus. J GEN VIROL , 85 1301 - 1312. 10.1099/vir.0.79888-0.

Duarte, RF; Delgado-Gonzalez, J; Quaglia, AF; Shaw, B; Wrench, D; Ethell, M; Dhillon, AP; ... Potter, MN; + view all (2004) Graft-versus-host disease of the liver: 109 cases from a single-centre. BONE MARROW TRANSPLANTATION , 33 S175 - S175.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; ... Quaglia, AF; + view all (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). In: BLOOD. (pp. 353B - 353B). AMER SOC HEMATOLOGY

Duke, V; Yogashangari, B; Gandini, D; Sherrington, PD; Mehta, A; Hoffbrand, AV; Foroni, L; (2004) Conserved amino acid sequences occur in a limited group of CLL patients with predominantly mutated IGH rearrangements. In: (pp. 552a-552a).

de Laat, HB; de Groot, PG; Mackie, IJ; Schoormans, S; Adam, M; Purdy, G; Woodhams, B; ... van Heerde, W; + view all (2004) The role of annexin A5 in the antiphospholipid syndrome. In: THROMBOSIS RESEARCH. (pp. 654 - 654). PERGAMON-ELSEVIER SCIENCE LTD

F

Feinberg, J; Fieschi, C; Doffinger, R; Feinberg, M; Leclerc, T; Boisson-Dupuis, S; Picard, C; ... Casanova, JL; + view all (2004) Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. EUROPEAN JOURNAL OF IMMUNOLOGY , 34 (11) pp. 3276-3284. 10.1002/eji.200425221.

Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Vadikolia, C; Wickremasinghe, RG; Casanova, AA; ... Ganeshaguru, K; + view all (2004) Zap-70 and 19V(H) mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents. In: BLOOD. (pp. 527A - 528A). AMER SOC HEMATOLOGY

Fricke, B; Jarvis, HG; Reid, CDL; Aguilar-Martinez, P; Robert, A; Quittet, P; Chetty, M; ... Stewart, GW; + view all (2004) Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction. BRIT J HAEMATOL , 125 (6) 796 - 803. 10.1111/j.1365-2141.2004.04965.x.

G

Gandini, D; Allen, AJ; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. Haematologica , 89 (5) pp. 613-615. Gold open access

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. HAEMATOLOGICA , 89 (5) 613 - 615. Gold open access

Garcia, CA; Robinson, J; Madrigal, AJ; Marsh, SGE; (2004) Killer cell immunoglobulin-like receptors (KIR). In: The EBMT handbook: Haemopoitic Stem Cell Transplantation. (pp. 48-55). European School of Haematology: Paris.

Garcia-Ortiz, JE; Cox, ST; Sandoval-Ramirez, L; Little, AM; Marsh, SGE; Madrigal, JA; Arguello, JR; (2004) A novel HLA-A allele: A*0257. TISSUE ANTIGENS , 63 (1) pp. 85-87. 10.1111/j.1399-0039.2004.00154.x.

Gerrard, G; Butters, TD; Mehta, AB; Hoffbrand, AV; Hughes, D; Burgess, M; Ganeshaguru, K; (2004) Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity. In: BLOOD. (pp. 334A - 334A). AMER SOC HEMATOLOGY

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; ... Ganeshaguru, K; + view all (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica , 89 (7) pp. 782-790.

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; ... Ganeshaguru, K; + view all (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. HAEMATOLOGICA , 89 (7) pp. 782-790. Gold open access

Ginhoux, F; Turbant, S; Gross, DA; Poupiot, J; Marais, T; Lone, Y; Lemonnier, FA; ... Davoust, J; + view all (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther , 10 (2) pp. 279-289. 10.1016/j.ymthe.2004.05.012.

Ginsberg, L; Beck, M; Ricci, R; Widmer, U; Mehta, A; (2004) Central nervous system manifestations of Fabry disease: experience from FOS, the Fabry Outcome Survey. JOURNAL OF NEUROLOGY , 251 p. 23.

Ginsberg, L; Richfield, L; Goodwin, S; Milligan, A; Valentine, A; Kendall, B; Zuckerman, J; (2004) Brain MRI appearances in Fabry disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 75 (5) 057-.

Gomez, K; Laffan, MA; Kemball-Cook, G; Pasi, J; Layton, M; Singer, JD; Tuddenham, EGD; (2004) Two novel mutations in severe factor VII deficiency. Br J Haematol , 126 (1) pp. 105-110. 10.1111/j.1365-2141.2004.04997.x.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, J-C; Garcia, L; Danos, O; (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science , 306 (5702) pp. 1796-1799. 10.1126/science.1104297.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, J-C; Garcia, L; Danos, O; (2004) [An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice]. Med Sci (Paris) , 20 (12) pp. 1163-1165. 10.1051/medsci/200420121163.

Gray, JT; Davidoff, AM; Nathwani, AC; (2004) A novel human factor IX expression cassette packaged as self-complementary DNA dimers in adeno-associated virus vectors results in dramatically improved liver transduction, significantly improving prospects for hemophilia B gene therapy. In: BLOOD. (pp. 869A - 869A). AMER SOC HEMATOLOGY

Grimwade, D; Gale, R; Hills, R; Kottaridis, P; Swirsky, D; Gilkes, A; Nugent, E; ... NCRI Adult Leukaemia Working Party, ; + view all (2004) The relationship between FLT3 mutation status, biological characteristics and outcome in patients with acute promyelocytic leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 69 - 69). BLACKWELL PUBLISHING LTD

Guinn, BA; Gilkes, AF; Mufti, GJ; Linch, D; Burnett, AK; Mills, KI; (2004) Use of cDNA microarray analysis to identify cancer testes antigen expression in presentation acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 125 51-.

H

Hall-Craggs, MA; Porter, J; Gatehouse, PD; Bydder, GM; (2004) Ultrashort echo time (UTE) MRI of the spine in thalassaemia. BRIT J RADIOL , 77 (914) 104 - 110. 10.1259/bjr/53300812.

Hart, DP; Thomson, KJ; Bannerjee, L; Morris, EC; Linch, DC; Goldstone, AH; Peggs, KS; (2004) Very low dose aciclovir prophylaxis postallogeneic stem cell transplantation prevents varicella zoster infection without development of clinically relevant resistance. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 30). BLACKWELL PUBLISHING LTD

Hassan-Walker, AF; Okwuadi, S; Lee, L; Griffiths, PD; Emery, VC; (2004) Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus. J MED VIROL , 74 (4) 573 - 579. 10.1002/jmv.20210.

Hernandez, D; Addou, S; Lee, D; Orengo, C; Shephard, EA; Phillips, IR; (2004) Trimethylaminuria and a human FMO3 mutation database. Human Mutation , 22 (3) pp. 209-213.

Hernandez, D; Janmohamed, A; Chandan, P; Phillips, IR; Shephard, EA; (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. PHARMACOGENETICS , 14 (2) 117 - 130. 10.1097/01.fpc.0000054152.92680.ea.

Hernandez, D; Janmohamed, A; Chandan, P; Phillips, IR; Shephard, EA; (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics , 14 (2) pp. 117-130.

Hewison, M; Zehnder, D; Chakraverty, R; Adams, JS; (2004) Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. MOLECULAR AND CELLULAR ENDOCRINOLOGY , 215 (1-2) 31 - 38. 10.1016/j.mce.2003.11.017.

Hough, RE; Faulkner, RD; Welch, JC; Vora, AJ; (2004) Efficacy of unrelated donor cord blood transplantation for poor risk paediatric haematological malignancies. In: (Proceedings) 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group. (pp. S126-S127). NATURE PUBLISHING GROUP

Hough, RE; Faulkner, RD; Welch, JC; Vora, AJ; (2004) Umbilical cord blood transplantation for paediatric haematological malignancies: single UK institution experience. In: (Proceedings) Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 28-29). BLACKWELL PUBLISHING LTD

Hughes, DA; Baker, RJ; Richfield, L; Milligan, A; Bruce, R; Mehta, AB; (2004) Balanced oral substrate reduction therapy for patients with mild to moderate Gaucher's disease: Initial results in clinical practice. In: BLOOD. (pp. 41B - 42B). AMER SOC HEMATOLOGY

Hughes, DA; Baker, RJ; Wright, F; Mehta, AB; (2004) The hypergammaglobinaemia of Gauchers disease is not reversed by enzyme replacement therapy. BRITISH JOURNAL OF HAEMATOLOGY , 125 p. 59.

Hughes, DA; Duke, VM; Baker, RJ; Wright, F; Foroni, L; Atul, MB; (2004) High prevalence of B-cell clonality in patients with Gaucher's disease. In: BLOOD. (pp. 657A - 657A). AMER SOC HEMATOLOGY

Hughes, DA; Li, A; Keshav, S; Mehta, A; (2004) Hepcidin dysregulation in patients with type 1 Gaucher's disease. In: BLOOD. (pp. 42B - 43B). AMER SOC HEMATOLOGY

Hughes, DA; Mehta, AB; (2004) Abnormal distribution of cell surface receptors in glycosphingolipid storage disorders: an in vitro model of Gaucher's and Fabry disease. BRITISH JOURNAL OF HAEMATOLOGY , 125 59 - 59.

Hughes, DA; Stuart-Smith, SE; Bain, BJ; (2004) How should stainable iron in bone marrow films be assessed? JOURNAL OF CLINICAL PATHOLOGY , 57 (10) pp. 1038-1040. 10.1136/jcp.2003.015834.

I

Israeli, D; Benchaouir, R; Ziaei, S; Rameau, P; Gruszczynski, C; Peltekian, E; Danos, O; (2004) FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J Cell Physiol , 201 (3) pp. 409-419. 10.1002/jcp.20088.

J

Jakupovic, I; Grandage, VL; Linch, DC; Khwaja, A; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. BLOOD , 103 (8) 3230 - 3232.

Jakupovic, I.; Grandage, V.L.; Linch, D.C.; Khwaja, A.; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. Blood , 103 (8) pp. 3230-3232. 10.1182/blood-2003-06-1985. Green open access
file

Janeway, C; Travers, P; Walport, M; Shlomick, M; (2004) Immunobiology: The immune system in health and disease. [Book]. (1 vols). (6th ed.). Garland Science: New York.

Janmohamed, A; Hernandez, D; Phillips, IR; Shephard, EA; (2004) Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). BIOCHEMICAL PHARMACOLOGY , 68 (1) pp. 73-83. 10.1016/j.bcp.2004.02.036.

Jennings, I; Mackie, I; Arnout, J; Preston, FE; UK Natl External Quality, ; (2004) Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UKNEQAS proficiency testing programme. J THROMB HAEMOST , 2 (12) 2178 - 2184.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; ... Wickremasinghe, RG; + view all (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; ... Wickremasinghe, RG; + view all (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood , 103 (5) pp. 1855-1861. 10.1182/blood-2003-05-1603. Green open access
file

K

Keeling, DM; Mackie, IJ; Moody, A; Watson, HG; Haemostasis Thrombosis Task Force, ; Brit Comm Standards Haematology, ; (2004) The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. BRIT J HAEMATOL , 124 (1) 15 - 25.

Khakoo, SI; Thio, CL; Martin, MP; Brooks, CR; Gao, XJ; Astemborski, J; Cheng, J; ... Carrington, M; + view all (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. SCIENCE , 305 (5685) 872 - 874.

Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; ... Goulder, PJR; + view all (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. NATURE , 432 (7018) pp. 769-774. 10.1038/nature03113.

Kroeger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... Marks, D; + view all (2004) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with multiple myeloma. In: BLOOD. (pp. 280A - 281A). AMER SOC HEMATOLOGY

Kroger, N; Thomson, K; Zabelina, T; Peggs, K; Chopra, R; Shimoni, A; Nagler, A; ... German Cooperative Transplant Grp, ; + view all (2004) Comparison between anti-thymocyte globulin and alemtuzumab as part of the melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies. In: BONE MARROW TRANSPLANTATION. (pp. S11 - S11). NATURE PUBLISHING GROUP

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; D'Sa, S; Taghipour, G; de Elvira, CR; ... Schmitz, N; + view all (2004) Patients with lymphoplasmacytic lymphoma can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 146 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 7A - 7A). AMER SOC HEMATOLOGY

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; Taghipour, G; de Elvira, CR; Linch, DC; ... Schmitz, N; + view all (2004) Role of allogeneic stem cell transplantation in lymphoplasmacytic lymphoma. Analysis of 61 cases from the European Bone Marrow Registry (EBMT). In: BLOOD. (pp. 909A - 909A). AMER SOC HEMATOLOGY

L

Ladesmaki, A; Kimby, E; Duke, V; Foroni, L; Hammarstroem, L; (2004) ATM mutations in B-cell chronic lymphocytic leukemia. HAEMATOLOGICA , 89 (1) pp. 109-110. Gold open access

Lajmi, AR; Sleep, S; Ng, C; Zhou, JF; Spence, YY; Davidoff, AM; Nathwani, AC; (2004) Scaleable membrane chromatography purification method for adeno-associated viral vectors. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U237 - U237). AMER CHEMICAL SOC

Laurence, A; Marin, D; Clark, R; Shepherd, P; Mackinnon, S; (2004) Frequency of blast crisis after achieving complete cytogenetic remission in first chronic phase CML patients who recieved imatinib therapy within six months of diagnosis. In: BLOOD. (pp. 292A - 292A). AMER SOC HEMATOLOGY

Linch, D; Goldstone, AH; Mackinnon, S; (2004) Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplantation , 34 (2) pp. 137-142. 10.1038/sj.bmt.1704538.

Lowe, GDO; Rumley, A; Mackie, IJ; (2004) Plasma fibrinogen. ANN CLIN BIOCHEM , 41 430 - 440.

M

Mackie, I; Yarranton, H; Machin, S; Pinkoski, L; Corash, L; (2004) Von Willebrand factor cleaving protease is retained in intercept plasma. In: TRANSFUSION. (pp. 102A - 102A). BLACKWELL PUBLISHING INC

Mackie, IJ; Lawrie, AS; Greenfield, RS; Guinto, ER; Machin, SJ; (2004) A new lupus anticoagulant test based on dilute prothrombin time. In: THROMBOSIS RESEARCH. (pp. 673 - 674). PERGAMON-ELSEVIER SCIENCE LTD

Mackie, IJ; de Laat, HB; Purdy, G; Adam, M; Woodhams, B; Derksen, RHWM; de Groot, PG; (2004) A prototype commercial ELISA for protein S antibodies. In: THROMBOSIS RESEARCH. (pp. 639 - 639). PERGAMON-ELSEVIER SCIENCE LTD

Mackinnon, S; Thomson, K; Morris, E; Kottaridis, PD; Peggs, KS; (2004) Reduced intensity transplantation: where are we now? HEMATOLOGY JOURNAL , 5 S34 - S38. 10.1038/sj.thj.6200419.

Madrigal, A; Rusakiewicz, S; Dodi, A; I, R; Robert, ; (2004) Immunotherapy with alloreactive T-cells? THE HEMATOLOGY JOURNAL , 5 (Suppl 3) S91-S95.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update April 2004. Hum Immunol , 65 (7) pp. 770-771.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Tissue Antigens , 64 (6) pp. 711-712. 10.1111/j.1399-0039.2004.00334.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Eur J Immunogenet , 31 (6) 279-. 10.1111/j.1365-2370.2004.00485.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Eur J Immunogenet , 31 (2) 101-. 10.1111/j.1365-2370.2004.00453.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Tissue Antigens , 64 (1) pp. 106-107. 10.1111/j.1399-0039.2004.00265.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Hum Immunol , 65 (7) 768-.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Eur J Immunogenet , 31 (2) 99-. 10.1111/j.1365-2370.2004.00451.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Tissue Antigens , 63 (6) pp. 619-620. 10.1111/j.0001-2815.2004.00254.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Hum Immunol , 65 (7) 767-. 10.1016/j.humimm.2004.05.005.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update July 2004. Hum Immunol , 65 (11) pp. 1411-1412. 10.1016/j.humimm.2004.09.013.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update June 2004. Hum Immunol , 65 (11) pp. 1409-1410. 10.1016/j.humimm.2004.09.012.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Eur J Immunogenet , 31 (2) 103-. 10.1111/j.1365-2370.2004.00454.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Tissue Antigens , 64 (1) pp. 108-109. 10.1111/j.1399-0039.2004.00266.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Hum Immunol , 65 (7) 769-.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Hum Immunol , 65 (1) pp. 90-91.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Tissue Antigens , 63 (2) pp. 190-191.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Tissue Antigens , 64 (6) pp. 713-714. 10.1111/j.1399-0039.2004.00335.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Eur J Immunogenet , 31 (6) 281-. 10.1111/j.1365-2370.2004.00486.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update April 2004. Eur J Immunogenet , 31 (4) pp. 195-196. 10.1111/j.1365-2370.2004.00468.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update August 2003. Tissue Antigens , 63 (1) pp. 98-99.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update December 2003. Tissue Antigens , 63 (5) pp. 505-506. 10.1111/j.1399-0039.2004.00213.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update July 2003. Tissue Antigens , 63 (1) pp. 96-97.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update June 2004. Eur J Immunogenet , 31 (4) pp. 199-200. 10.1111/j.1365-2370.2004.00472.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update May 2004. Eur J Immunogenet , 31 (4) pp. 197-198. 10.1111/j.1365-2370.2004.00469.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update November 2003. Tissue Antigens , 63 (5) pp. 503-504. 10.1111/j.0001-2815.2004.00212.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update October 2003. Tissue Antigens , 63 (5) pp. 501-502. 10.1111/j.0001-2815.2004.00211.x.

Martineau, Y; Le Bec, C; Monbrun, L; Allo, V; Chiu, I-M; Danos, O; Moine, H; ... Prats, A-C; + view all (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol , 24 (17) pp. 7622-7635. 10.1128/MCB.24.17.7622-7635.2004.

Mathias, MC; Mackie, I; Khair, K; Machin, SJ; Liesner, R; (2004) Defective fibrinolysis in children with severe haemophilia A. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2004) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 pp. 107-109.

McCabe, D.J.H.; Harrison, P.; Mackie, I.J.; Sidhu, P.S.; Purdy, G.; Lawrie, A.S.; Watt, H.; ... Machin, S.J.; + view all (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. British Journal of Haematology , 125 (6) pp. 777-787. 10.1111/j.1365-2141.2004.04983.x.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Purdy, G; Lawrie, AS; Watt, H; ... Machin, SJ; + view all (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. BRIT J HAEMATOL , 125 (6) 777 - 787. 10.1111/j.1365-2141.2004.04983.x.

McCabe, DJH; Harrison, P; Sidhu, PS; Mackie, IJ; Purdy, G; Lawrie, AS; Watt, H; ... Brown, MM; + view all (2004) Leucocyte-platelet complex formation is increased in patients with acute symptomatic compared with asymptomatic severe carotid stenosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 522 - 522). B M J PUBLISHING GROUP

McCann, S; Byrne, JL; Rovira, M; Shaw, P; Ribaud, P; Sica, S; Volin, L; ... Cordonnier, C; + view all (2004) Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. BONE MARROW TRANSPLANTATION , 33 (5) pp. 519-529.

Mehta, A; Beck, M; Ricci, R; Widmer, U; (2004) Fabry disease defined: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (6) p. 450.

Mehta, A; Beck, M; Ricci, R; Widmer, U; Sunder-Plassmann, G; (2004) Fabry outcome survey: need for documentation of dermatological, ophthalmologic and psychiatric affections: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (7) p. 517. 10.1111/j.1365-2362.2004.01374.x.

Mehta, A; Ricci, R; Widmer, U; Dehout, F; de Lorenzo, AG; Kampmann, C; Linhart, A; ... Beck, M; + view all (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (3) pp. 236-242. 10.1111/j.1365-2362.2004.01309.x.

Meja, KK; Catley, MC; Cambridge, LM; Barnes, PJ; Lum, H; Newton, R; Giembycz, MA; (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther , 309 (2) pp. 833-844. 10.1124/jpet.103.060020.

Morris, E; Thomson, K; Craddock, C; Mahendra, P; Milligan, D; Cook, G; Smith, GM; ... Mackinnon, S; + view all (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. BLOOD , 104 (13) 3865 - 3871. 10.1182/blood-2004-03-1105.

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, G; Parker, A; Schey, S; ... Mackinnon, S; + view all (2004) Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING LTD

Morris, E.; Thomson, K.; Craddock, C.; Mahendra, P.; Milligan, D.; Cook, G.; Smith, G.M.; ... Mackinnon, S.; + view all (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood , 104 (13) pp. 3865-3871. 10.1182/blood-2004-03-1105. Green open access
file

Morsi, H; Yong, KL; Jewell, AP; (2004) Evaluation of the Taguchi methods for the simultaneous assessment of the effects of multiple variables in the tumour microenvironment. International Seminars in Surgical Oncology , 1 10.1186/1477-7800-1-7.

N

Narat, S; Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Jones, DT; Hart, SM; ... Ganeshaguru, K; + view all (2004) The role of multidrug resistance proteins and drug sensitivity in relation to poor prognosis identified by ZAP-70 expression and IgV(H) mutation status in B-CLL. In: BLOOD. (pp. 281B - 281B). AMER SOC HEMATOLOGY

Narat, S; Gandla, J; Mehta, A; (2004) Anti-CD20 monoclonal antibody in the treatment of refractory auto-immune cytopenias in adults. In: (pp. 742a-742a).

Nash, M; Camilleri, R; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, M; Camilleri, R; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta2GP1/Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, M.J.; Camilleri, R.S.; Kunka, S.; Mackie, I.J.; Machin, S.J.; Cohen, H.; (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. Journal of Thrombosis and Haemostasis , 2 (7) pp. 1077-1081. 10.1111/j.1538-7836.2004.00810.x.

Nash, MJ; Camilleri, RS; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 49). BLACKWELL PUBLISHING LTD

Nash, MJ; Camilleri, RS; Kunka, S; Mackie, IJ; Machin, SJ; Cohen, H; (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 2 (7) 1077 - 1081.

Nash, MJ; Camilleri, RS; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta(2)-glycoprotein I Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING LTD

Nash, MJ; Cohen, H; (2004) Management of Jehovah's Witness patients with haematological problems. BLOOD REV , 18 (3) 211 - 217. 10.1016/S0268-960X(03)00065-1.

Nash, MJ; Mackie, IJ; Cohen, H; Machin, SJ; (2004) Antiphospholipid antibodies can reduce the in vitro cleavage of domain V of beta2-glycoprotein I by plasmin. In: THROMBOSIS RESEARCH. (pp. 616 - 616). PERGAMON-ELSEVIER SCIENCE LTD

Nash, MJ; Mackie, IJ; Machin, SJ; (2004) Kallikrein is able to specifically cleave beta2-glycoprotein I in domain V. In: THROMBOSIS RESEARCH. (pp. 620 - 620). PERGAMON-ELSEVIER SCIENCE LTD

Nathwani, AC; Benjamin, R; Nienhuis, AW; Davidoff, AM; (2004) Current status and prospects for gene therapy. VOX SANG , 87 (2) 73 - 81.

Nathwani, AC; Davidoff, AM; Tuddenham, EGD; (2004) Prospects for gene therapy of haemophilia. HAEMOPHILIA , 10 (4) 309 - 318. 10.1111/j.1365-2516.2004.00926.x.

Nivsarkar, MS; Nathwani, A; Mosley, K; Davies, N; Gregory, LG; David, AL; Themis, M; ... Waddington, SN; + view all (2004) Testosterone induced increase in transgene expression in vivo using Adenoviral Gene Delivery Vectors. Presented at: 1st Annual Conference of the British-Society-for-Gene-Therapy, Keble Coll, Oxford, ENGLAND.

O

O'Connell, NM; McIntosh, JH; Riddell, A; Pascoe, G; Griffioen, A; Lee, CA; Perry, DJ; (2004) Thrombin generation and correlation with bleeding tendency in inherited FXI deficiency. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 44 - 44). BLACKWELL PUBLISHING LTD

Orteu, CH; Jansen, T; Beck, M; Mehta, A; Ricci, R; Widmer, U; (2004) The Fabry Outcome Survey is a useful tool to document the natural history of Fabry disease. British Journal of Dermatology , 151 p. 9.

P

Parini, R; Ramaswami, U; Whybra, C; Mehta, A; Ricci, R; Widmer, U; Beck, M; (2004) Diagnosis of Anderson-Farry disease in childhood. What should we focus on? Pediatric Research , 56 (3) 207-.

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUMAN IMMUNOLOGY , 65 (5) pp. 544-549.

Peggs, K; (2004) Imatinib mesylate - gold standards and silver linings. CLIN EXP MED , 4 (1) 1 - 9. 10.1007/s10238-004-0032-5.

Peggs, K; Mackinnon, S; (2004) Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion? LEUKEMIA , 18 (9) 1541 - 1542. 10.1038/sj.leu.2403432.

Peggs, K; Mackinnon, S; Ayuk, FA; Zander, AR; Kröger, N; (2004) Graft-versus-myeloma: Are durable responses a clinical reality following donor lymphocyte infusion? (multiple letters) (2). Leukemia , 18 (9) pp. 1541-1543.

Peggs, KS; (2004) Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther , 2 (4) pp. 559-573.

Peggs, KS; (2004) Immune reconstitution following stem cell transplantation. LEUKEMIA LYMPHOMA , 45 (6) 1093 - 1101. 10.1080/10428190310001641260.

Peggs, KS; (2004) Role of MabCampath in allogeneic transplantation. Ann Hematol , 83 Sup S66-S68. 10.1007/s00277-004-0850-2.

Peggs, KS; Mackinnon, S; (2004) Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-Cell therapy. HUM IMMUNOL , 65 (5) 550 - 557. 10.1016/j.humimm.2004.02.016.

Peggs, KS; Mackinnon, S; (2004) Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. INT J BIOCHEM CELL B , 36 (4) 695 - 701. 10.1016/j.biocel.2003.08.008.

Peggs, KS; Mackinnon, S; (2004) Immune reconstitution following haematopoietic stem cell transplantation. BRIT J HAEMATOL , 124 (4) 407 - 420. 10.1046/j.1365-2141.2003.04767.x.

Peggs, KS; Sureda, A; Hunter, A; Caballero, MD; Cavet, J; Urbano-Ispizua, A; Parker, A; ... Mackinnon, S; + view all (2004) Impact of in vivo T-cell depletion on outcome following reduced intensity transplantation for Hodgkin lymphoma: Comparison between 2 prospective studies. In: BLOOD. (pp. 230A - 230A). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Hart, DP; Geary, J; Morris, EC; Yong, K; Goldstone, AH; ... Mackinnon, S; + view all (2004) Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses. BLOOD , 103 (4) 1548 - 1556.

Peggs, KS; Thomson, K; Hunter, A; Chopra, R; Mahendra, P; Milligan, D; Parker, A; ... Mackinnon, S; + view all (2004) Exploiting alloreactivity in relapsed and refractory Hodgkin Lymphoma: long-term follow-up of a T-cell-depleted reduced intensity transplant protocol. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 4). BLACKWELL PUBLISHING LTD

Peggs, KS; Verfuerth, S; Chow, C; Thomson, K; Goldstone, AH; Linch, DC; Mackinnon, S; (2004) Adoptive cellular therapy for cytomegalovirus following allogeneic stem cell transplantation: Toxicity and efficacy. In: BLOOD. (pp. 59A - 59A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzy, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2004) Adoptive cellular therapy for early cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T-cell lines. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 199.

Perez, N; Bigey, P; Scherman, D; Danos, O; Piechaczyk, M; Pelegrin, M; (2004) Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet Vaccines Ther , 2 (1) 2-. 10.1186/1479-0556-2-2. Gold open access

Porakishvili, N; Kardava, L; Jewell, AP; Yong, K; Glennie, MJ; Akbar, A; Lydyard, PM; (2004) Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Haematologica , 89 (4) pp. 435-443. Gold open access

Porakishvili, N; Kulikova, N; Manoussaka, M; Jewell, AP; Youinou, PY; Nedelec, S; Yong, K; ... Lydyard, PM; + view all (2004) Differential expression of CD180 and sIgM by B chronic lymphocytic leukaemia cells (B-CLL) using mutated and unmutated IgVh genes. In: BLOOD. (pp. 768A - 768A). AMER SOC HEMATOLOGY

Porakishvili, N; Manoussaka, M; Kulikova, N; Walton, J; Nathwani, A; Jewell, AP; Stevenson, F; ... Lydyard, PM; + view all (2004) Activation and proliferation of B cell chronic lymphocytic leukaemia (B-CLL) cells through anti-CD180, Anti-CD40 and IL-4. In: BLOOD. (pp. 277B - 277B). AMER SOC HEMATOLOGY

Q

Quezada, SA; Jarvinen, LZ; Lind, EE; Noelle, RJ; (2004) CD40/CD154 interactions at the interface of tolerance and immunity. ANNU REV IMMUNOL , 22 307 - 328. 10.1146/annurev.immunol.22.012703.104533.

R

Raslova, H; Komura, E; Le Couédic, JP; Larbret, F; Debili, N; Feunteun, J; Danos, O; ... Favier, R; + view all (2004) FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest , 114 (1) pp. 77-84. 10.1172/JCI21197.

Roberts, CH; Robinson, J; Dodi, IA; Madrigal, JA; Marsh, SGE; (2004) The European searchable tumour cell line database (ESTDAB). Genes and Immunity , 5 44-.

Roberts, CH; Robinson, J; Dodi, IA; Madrigal, JA; Marsh, SGE; (2004) The European searchable tumour cell line database (ESTDAB). In: (Proceedings) 18th European Histocompatibility Conference. (pp. S11-S11). NATURE PUBLISHING GROUP

Robinson, J; Garcia, CA; Waller, MJ; Madrigal, JA; Marsh, SGE; (2004) The immuno polymorphism database. In: (Proceedings) 18th European Histocompatibility Conference. (pp. S11-S11). NATURE PUBLISHING GROUP

Rost, S; Fregin, A; Ivaskevicius, V; Conzelmann, E; Hörtnagel, K; Pelz, H-J; Lappegard, K; ... Oldenburg, J; + view all (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature , 427 (6974) pp. 537-541. 10.1038/nature02214.

Rusakiewicz, S; Dodi, IA; Loconto, J; Travers, PJ; Madrigal, JA; (2004) Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells, Molecules, and Diseases , 33 (3) p. 191.

S

Self, R; Mackie, I; Jenkins, A; Sanders, J; Williams, A; Machin, S; Mythen, M; (2004) Use of the Thrombelastograph (R) to assess the in vitro effects of DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass. In: BRITISH JOURNAL OF ANAESTHESIA. (pp. 318P - 318P). OXFORD UNIV PRESS

Self, R; Mackie, IJ; Williams, AM; Jenkins, AMC; Mythen, MG; (2004) Activated thrombelastograph reaction (r) time is contact factor dependent and prolonged by DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass. In: (pp. A270-).

Shah, FT; Chatterjee, R; Owusu- Asante, M; Porter, JB; (2004) Adults with severe sickle cell anaemia and iron overload have a high incidence of osteopenia and osteoporosis. In: BLOOD. (pp. 468A - 468A). AMER SOC HEMATOLOGY

Shah, FT; Rafique, R; Evan, P; Porter, JB; (2004) Decreased serum pro-hepcidin in thalassaemia intermedia; a mechanism for increased iron absortion mediated though ineffective erthropoiesis and NTBI? In: BLOOD. (pp. 982A - 982A). AMER SOC HEMATOLOGY

Shah, JS; Mehta, A; Hughes, D; Ward, D; Tome, M; Sachdev, B; Lee, P; (2004) Arrhythmia in Anderson-Fabry disease. In: EUROPEAN HEART JOURNAL. (pp. 539 - 539). W B SAUNDERS CO LTD

Shah, JS; Mehta, AB; Hughes, D; (2004) Arrhythmia in Anderson-Fabry Disease. Presented at: UNSPECIFIED.

Shah, JS; Thaman, R; Hughes, D; Murphy, R; Lee, P; Mehta, A; McKenna, WJ; (2004) The natural history of left ventricular systolic function in Anderson Fabry's disease (AFD). In: HEART. (pp. A59 - A59). B M J PUBLISHING GROUP

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPLANTATION , 34 (4) pp. 367-368.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPL , 34 (4) 367 - 368. 10.1038/sj.bmt.1704586.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; Elsner, HA; Blasczyk, R; (2004) Scoring for HLA matching? A clinical test of HistoCheck (multiple letters) [1]. Bone Marrow Transplantation , 34 (4) pp. 367-369. 10.1038/sj.bmt.1704586.

Shaw, BE; Maldonado, H; Madrigal, JA; Smith, C; Petronzelli, F; Mayor, NP; Potter, MN; ... Marsh, SGE; + view all (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens , 63 (5) pp. 401-411. 10.1111/j.0001-2815.2004.00218.x.

Shaw, BE; Maldonaldo, H; Madrigal, JA; Smith, C; Petronzelli, F; Mayor, NP; Potter, MN; ... Marsh, SGE; + view all (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. TISSUE ANTIGENS , 63 (5) 401 - 411.

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Increased disease relapse in HLA-DPB1 matched recipients of unrelated donor transplants is not confined to pairs matched for the other five HLA loci. In: BLOOD. (pp. 236A - 237A). AMER SOC HEMATOLOGY

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Matching status at amino acid positions 57 and 65 of the HLA-DPB1 beta chain determines outcome in recipients of unrelated donor haematopoietic stem cell transplants. In: BLOOD. (pp. 236A - 236A). AMER SOC HEMATOLOGY

Sinclair, PB; Sorour, A; Martineau, M; Harrison, CJ; Mitchell, WA; O'Neill, E; Foroni, L; (2004) A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. CANCER RESEARCH , 64 (12) pp. 4089-4098. 10.1158/0008-5472.CAN-03-1871.

Spicer, J; Smith, P; Maclennan, K; Hoskin, P; Hancock, B; Linch, D; Pettengell, R; (2004) Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma. British Journal of Cancer , 90 (6) pp. 1151-1155. 10.1038/sj.bjc.6601675.

Springfeld, C; Fielding, A; Peng, KW; Galanis, E; Russell, SJ; Cattaneo, R; (2004) Measles virus: Improving natural oncolytic properties by genetic engineering. In: Viral Therapy of Human Cancers. (pp. 459-480).

Stainsby, D; Cohen, H; Jones, H; (2004) The 2003 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; Cohen, H; Jones, H; Beatty, C; Williamson, LM; (2004) Transfusion related lung injury: a major cause of transfusion associated mortality and morbidity. In: (Proceedings) British society for haematology annual scientific meeting.

Steele, AJ; Casanova, AA; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Jones, DT; Wickremasinghe, RG; (2004) The sesquiterpene lactone parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukemia cells. In: (pp. 949a-949b).

Steele, AJ; Casanova, AA; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Jones, DT; Wickremasinghe, RG; (2004) The sesquiterpene lactone parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukemia cells. In: BLOOD. (pp. 949A - 950A). AMER SOC HEMATOLOGY

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta. In: SURGERY. (pp. 183 - 189). MOSBY, INC

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-α/β. Surgery , 136 (2) pp. 183-189. 10.1016/j.surg.2004.04.014.

Streck, CJ; Zhou, JF; Ng, CY; Zhang, YB; Nathwani, AC; Davidoff, AM; (2004) Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , 199 (1) 78 - 86.

Sunder-Plassmann, G; Dehout, F; Schwarting, A; de Lorenzo, AG; Ricci, R; Kampmann, C; Beck, M; ... Widmer, U; + view all (2004) Uncontrolled hypertension in Fabry disease. American Journal of Hypertension , 17 (5) 475-.

T

Tanriverdi, F; Gonzalez-Martinez, D; Silveira, LFG; Hu, Y; Maccoll, GS; Travers, P; Bouloux, PMG; (2004) Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II. EXP CLIN ENDOCR DIAB , 112 (10) 587 - 594. 10.1055/s-2004-830404.

Tauro, S; Craddock, C; Peggs, K; Begum, G; Chopra, R; Littlewood, T; Parker, A; ... Mackinnon, S; + view all (2004) Outcome of allogeneic stem cell transplantation in adults with high-risk myeloid malignancies using an alemtuzemab based reduced-intensity-conditioning regimen. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 3). BLACKWELL PUBLISHING LTD

Thomson, KJ; Ings, S; Watts, M; Mackinnon, S; Peggs, KS; (2004) CD34(+) cell dose and the occurrence of GVHD in the presence of in vivo T-cell depletion. BLOOD , 103 (2) 743 - 743.

V

Vig, S; Chitolie, A; Sleight, S; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2004) Prevalence and risk of thrombophilia defects in vascular patients. EUR J VASC ENDOVASC , 28 (2) 124 - 131. 10.1016/j.ejvs.2004.03.027.

Vig, S; Sleight, S; Chitolie, A; Bevan, DH; Thompson, MM; Dormandy, J; Halliday, A; (2004) Identification of a high-risk subgroup in patients with coronary and peripheral arterial disease. In: BRITISH JOURNAL OF SURGERY. (pp. 143 - 143). JOHN WILEY & SONS LTD

Vig, S; Sleight, S; Chitolie, A; Bevan, DH; Thompson, MM; Dormandy, J; Halliday, A; (2004) Prevalence of thrombophilia in patients with coronary artery and peripheral vascular disease. In: BRITISH JOURNAL OF SURGERY. (pp. 1234 - 1234). JOHN WILEY & SONS LTD

Virchis, A; Koh, M; Rankin, P; Mehta, A; Potter, M; Hoffbrand, AV; Prentice, HG; (2004) Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY , 124 (1) pp. 26-32. 10.1046/j.1365-2141.2003.04728.x.

W

Waddington, S.N.; Nivsarkar, M.S.; Mistry, A.R.; Buckley, S.M.K.; Kemball-Cook, G.; Mosley, K.L.; Mitrophanous, K.; ... Coutelle, C.; + view all (2004) Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood , 104 (9) pp. 2714-2721. 10.1182/blood-2004-02-0627.

Waddington, SN; Nivsarkar, M; Mistry, A; Buckley, SMK; Kemball-Cook, G; Mosley, KL; Mitrophanous, K; ... Coutelle, C; + view all (2004) Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy. In: JOURNAL OF GENE MEDICINE. (pp. S17 - S17). JOHN WILEY & SONS LTD

Waddington, SN; Nivsarkar, MS; Mistry, AR; Buckley, SMK; Kemball-Cook, G; Mosley, KL; Mitrophanous, K; ... Coutelle, C; + view all (2004) Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. BLOOD , 104 (9) 2714 - 2721. 10.1182/blood-2004-02-0627.

Waddington, SN; Nivsarkar, MS; Mistry, AR; Buckley, SMK; Kemball-Cook, G; Mosley, KL; Mitrophanous, K; ... Coutelle, C; + view all (2004) Permanent phenotypic correction of haemophilia B in immunocompetent mice by prenatal gene therapy. In: MOLECULAR THERAPY. (pp. S15 - S15). ACADEMIC PRESS INC ELSEVIER SCIENCE

Walsh, V; Gilkes, AF; Sweeney, M; Austin, SJ; Gale, RE; Mills, KI; (2004) Rapid and quantitative detection of mutations of the FLT3 gene in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 68 - 69). BLACKWELL PUBLISHING LTD

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2004) Perforin expressing CD4+T cells respond to CMV antigens in CMV seropositive patients with B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 280B - 280B). AMER SOC HEMATOLOGY

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Leverett, D; Linch, DC; (2004) Successful customization of peripheral blood stem cell harvest volume and cell concentration during apheresis. In: BLOOD. (pp. 330B - 330B). AMER SOC HEMATOLOGY

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Linch, DC; (2004) Thermally induced catastrophic cryocyte breaks. In: BONE MARROW TRANSPLANTATION. (pp. S309 - S309). NATURE PUBLISHING GROUP

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Eze, A; Ramoton, P; Weil-Weiner, Y; (2004) Plasma 'free' HB is related to red cell derived vesicle numbers in sickle cell anemia and thalassemia intermedia: Implications for nitric oxide (NO) scavenging and pulmonary hypertension. In: BLOOD. (pp. 465A - 465A). AMER SOC HEMATOLOGY

Whitelegg, A; Barber, LD; (2004) The structural basis of T-cell allorecognition. TISSUE ANTIGENS , 63 (2) pp. 101-108.

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2004) Patient self-testing of INR is a safe and acceptable alternative to laboratory-based testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 56 - 57). BLACKWELL PUBLISHING LTD

Williams, KE; Gardiner, C; Mackie, IJ; machin, SJ; Cohen, H; (2004) Patient self-testing of the INR is a safe and acceptable alternative to laboratory-based testing. In: (Proceedings) British society for haematology annual scientific meeting.

Y

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2004) Amotosalen hydrochloride (S-59) and UVA light treatment of cryosupernatant has no clinically significant effect on haemostatic proteins and appears suitable for plasma exchange in thrombotic thrombocytopenic purpura. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 34 - 34). BLACKWELL PUBLISHING LTD

Yarranton, H; Lawrie, AS; Purdy, G; Mackie, IJ; Machin, SJ; (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. TRANSFUSION MED , 14 (1) 39 - 44.

Yung, L; Smith, P; Hancock, BW; Hoskin, P; Gilson, D; Vernon, C; Linch, DC; (2004) Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. LEUKEMIA LYMPHOMA , 45 (8) 1579 - 1585. 10.1080/1042819042000209404.

Z

Zal, B; Kaski, JC; Arno, G; Akiyu, JP; Xu, Q; Cole, D; Whelan, M; ... Baboonian, C; + view all (2004) Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation , 109 (10) pp. 1230-1235. 10.1161/01.CIR.0000118476.29352.2A.

This list was generated on Sun May 19 04:45:35 2019 BST.